New PET scan could help track prostate cancer treatment success
NCT ID NCT04158245
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This study looked at whether a special PET scan (18F-fluciclovine) can show how well treatments are working in men with advanced prostate cancer that no longer responds to hormone therapy. Nine men were given standard treatments like abiraterone, enzalutamide, or docetaxel. The PET scan was done before and 12 weeks after starting treatment to see if it could detect changes in the cancer better than regular CT or bone scans. The goal was to learn if this scan can help doctors monitor treatment response more accurately.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tulane Cancer Center Clinic
New Orleans, Louisiana, 70112, United States
Conditions
Explore the condition pages connected to this study.